A

Apollo Hospital | Hyderabad, India

Research site
(Unclaimed)
Location
Apollo Research & Innovation (ARI) 1st Floor, Auditorium Building, Apollo Health City, Jubilee Hills, Hyderabad, Telangana, India
Site insights

Top conditions

Plasma Cell Cancer (2 trials)

Non-Small-Cell Lung Carcinoma (2 trials)

Invasive Fungal Infections (2 trials)

Aspergillosis (2 trials)

Mycoses (2 trials)

Top treatments

Isavuconazole
Darbepoetin Alfa
Pitavastatin
Simvastatin
Docetaxel
Ramipril
Belimumab
PF-00489791
Kyprolis
Ceftazidime

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

1 of 18
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

To characterize safety associated with the use of Kyprolis under the locally approved label.

Active, not recruiting
Relapsed Refractory Multiple Myeloma
Drug: Drug: Carfilzomib + Dexamethasone
Drug: Drug: Carfilzomib + Lenalidomide + Dexamethasone

Trial sponsors

Pfizer logo

Pfizer (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems